Optimizing phase II of drug development for disease‐modifying compounds
Year: 2008
Type: article
Source: Alzheimer s & Dementia
Author: Jeffrey L. Cummings
Institution: University of California, Los Angeles
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2166949035
